JP Morgan Private Wealth Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-9,360
| Closed | -$1.72M | – | 2016 |
|
|
2021
Q2 | $1.72M | Buy |
9,360
+5,783
| +162% | +$993K | ﹤0.01% | 938 |
|
|
2021
Q1 | $547K | Sell |
3,577
-2,064
| -37% | -$319K | ﹤0.01% | 1277 |
|
|
2020
Q4 | $881K | Sell |
5,641
-1,214
| -18% | -$156K | ﹤0.01% | 1051 |
|
|
2020
Q3 | $784K | Buy |
6,855
+766
| +13% | +$82.6K | ﹤0.01% | 985 |
|
|
2020
Q2 | $683K | Buy |
6,089
+1,593
| +35% | +$169K | ﹤0.01% | 950 |
|
|
2020
Q1 | $404K | Sell |
4,496
-1,234
| -22% | -$121K | ﹤0.01% | 1013 |
|
|
2019
Q4 | $620K | Buy |
5,730
+1,583
| +38% | +$169K | ﹤0.01% | 965 |
|
|
2019
Q3 | $406K | Buy |
4,147
+910
| +28% | +$103K | ﹤0.01% | 1069 |
|
|
2019
Q2 | $424K | Sell |
3,237
-801
| -20% | -$103K | ﹤0.01% | 1042 |
|
|
2019
Q1 | $546K | Buy |
4,038
+249
| +7% | +$31K | ﹤0.01% | 997 |
|
|
2018
Q4 | $369K | Buy |
3,789
+966
| +34% | +$114K | ﹤0.01% | 1077 |
|
|
2018
Q3 | $392K | Sell |
2,823
-1,153
| -29% | -$145K | ﹤0.01% | 1175 |
|
|
2018
Q2 | $493K | Sell |
3,976
-5
| -0.1% | -$584 | ﹤0.01% | 1013 |
|
|
2018
Q1 | $444K | Buy |
3,981
+1,739
| +78% | +$208K | ﹤0.01% | 907 |
|
|
2017
Q4 | $268K | Sell |
2,242
-52
| -2% | -$6.33K | ﹤0.01% | 1088 |
|
|
2017
Q3 | $322K | Sell |
2,294
-38
| -2% | -$5.16K | ﹤0.01% | 997 |
|
|
2017
Q2 | $284K | Sell |
2,332
-4,384
| -65% | -$510K | ﹤0.01% | 1032 |
|
|
2017
Q1 | $815K | Sell |
6,716
-3,884
| -37% | -$501K | 0.01% | 696 |
|
|
2016
Q4 | $1.3M | Buy |
10,600
+518
| +5% | +$63.4K | 0.01% | 529 |
|
|
2016
Q3 | $1.24M | Sell |
10,082
-1,163
| -10% | -$150K | 0.01% | 539 |
|
|
2016
Q2 | $1.31M | Buy |
11,245
+3,206
| +40% | +$455K | 0.01% | 528 |
|
|
2016
Q1 | $1.12M | Buy |
8,039
+232
| +3% | +$34.1K | 0.01% | 526 |
|
|
2015
Q4 | $1.49M | Buy |
7,807
+1,842
| +31% | +$322K | 0.02% | 438 |
|
|
2015
Q3 | $933K | Sell |
5,965
-6,041
| -50% | -$1.1M | 0.01% | 487 |
|
|
2015
Q2 | $2.17M | Buy |
12,006
+3,036
| +34% | +$524K | 0.02% | 353 |
|
|
2015
Q1 | $1.55M | Sell |
8,970
-487
| -5% | -$88.2K | 0.02% | 425 |
|
|
2014
Q4 | $1.75M | Sell |
9,457
-443
| -4% | -$82.1K | 0.02% | 408 |
|
|
2014
Q3 | $1.64M | Buy |
9,900
+1,167
| +13% | +$192K | 0.02% | 409 |
|
|
2014
Q2 | $1.36M | Buy |
8,733
+1,615
| +23% | +$255K | 0.02% | 347 |
|
|
2014
Q1 | $1.08M | Buy |
+7,118
| New | +$1.13M | 0.02% | 388 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM